Editorial Recommends FDA Implement Further Strategies to Protect Patients Seeking Cosmetic Stem-Cell Treatments

An editorial published recently in the Aesthetic Surgery Journal calls for the FDA to expedite its oversight of companies and clinics offering stem-cell products and therapies.